STAT
Inside the quest to find a place in modern medicine for magic mushrooms as a treatment for depression, other mental illnesses
Today, with a net worth of roughly $400 million accrued through various enterprises, [German financier Christian] Angermayer is one of ...
‘Uncharted territory’: Doctors struggle with patient demand for unproven CBD supplements
[Jacqueline] French, a neurologist at New York University’s Langone Health, tries to steer her patients away from sprinting to the ...
Viewpoint: We must embrace ‘risk taking’ in the quest to cure Alzheimer’s
For common neurodegenerative diseases like Alzheimer’s, nothing has worked so far to slow the course of the disease in spite ...
Here’s how artificial intelligence could ‘poison’ healthcare
Artificial intelligence is often hailed as a great catalyst of medical innovation, a way to find cures to diseases that ...
Podcast: Talking CRISPR with controversial biohacker Josiah Zayner
Is biohacking a crime? Who came up with the latest CRISPR trick? And did Rage Against the Machine sell out? ...
5 ways we could pay for expensive life-saving gene therapies
We have arrived at a special moment in health care. Innovative, life-changing gene therapies are here that will cure or ...
US patent office reopens Broad Institute—University of California CRISPR patent dispute
The U.S. patent office has declared an interference between a dozen key patents awarded to the Broad Institute on the ...
Why we can’t do anything about a Russian scientist’s plans to create more CRISPR babies
Two influential leaders in science for the first time publicly condemned a Russian biologist who said he plans to produce ...
Controversial new drug meant to increase sexual desire in women is approved for sale
The Food and Drug Administration approved a controversial drug meant to increase women’s desire for sex, a treatment that has ...
Scammers set sights on booming genetic testing market
The cost of genetic testing for disease assessment can be as high as $10,000. With that kind of money in ...
Biohacker Josiah Zayner meets with California regulators investigating him: ‘It was surreal’
A few weeks ago, the prominent biohacker Josiah Zayner took to Instagram to break some news: He had received a ...
Viewpoint: US government’s clinical trial registry plagued by ‘bogus’ patient-funded stem-cell trials
When a judge ruled [June 3] that the FDA could stop the work of U.S. Stem Cell, the firm’s trials ...
Could a virus be causing mysterious ‘polio-like’ disease affecting children?
Researchers say they have strong new evidence that a virus is involved in a rare and puzzling polio-like condition that ...
‘Jumping genes’ may help CRISPR make precision edits of disease-causing DNA
[In a 2017 study] four biologists wrote that “it has not escaped our notice” that a funny little “jumping gene” ...
Viewpoint: Congressional proposal to loosen court ruling that blocked companies from patenting genes could ‘stifle’ science innovation
In 2013, the U.S. Supreme Court ruled in favor of innovation when it struck down a patent that gave one ...
Making eggs and sperm from stem cells would create ‘ethical, social and legal conundrums’
Until recently, the only way to make eggs or sperm was the old-fashioned way: in the ovaries and testes. In ...
Viewpoint: Working with drug companies to help terminally ill patients gain access to experimental drugs
My colleagues and I at New York University’s Division of Medical Ethics quickly recognized that right to try could not ...
Making a case against ‘aggressive’ restrictions on opioid prescriptions
[Stefan] Kertesz, a primary care physician who also specializes in addiction medicine, had not spent his career investigating long-term opioid ...
Why we need to be skeptical of claims about the benefits of brain wearables
[Brain] wearables are touted as ways to curb stress, sleep better, boost creativity or athleticism, or even address serious medical ...
Ethical ‘quagmire’: How one ALS patient got in line for a therapy never tested in humans
The FDA gave Jaci Hermstad, a 25-year old Iowan who is dying from a rare form of ALS, an early ...
Some powerful new cancer drugs trigger diabetes for unknown reasons
The first two rounds of treatment went off without a hitch. But last November, after receiving a third dose of ...
Viewpoint: Outrage over $2 million price tag for new gene therapy is perplexing and disappointing
As someone who has lived with spinal muscular atrophy for all 30 years of my life, I was perplexed and ...
Congress renews ban on editing human embryos, despite calls from scientists touting research benefits
A House committee on Tuesday [June 4] restored to pending legislation a ban on altering the genomes of human embryos ...
Video: Alzheimer’s and the disappointing history of amyloid research
The idea that sticky brain plaques cause Alzheimer’s disease began as an interesting hypothesis and eventually became drug industry dogma. Now, ...
Why the results of your genetic ancestry test will change over time
23andMe caused Leonard Kim not one identity crisis but two. The first came in 2016, when Kim, who was raised ...
Google’s AI beats human doctors at diagnosing lung cancer in study
One of lung cancer’s most lethal attributes is its ability to trick radiologists. Some nodules appear threatening but turn out ...
Computer-based ‘brain-training’ program could aid veterans who suffer traumatic injuries
It has been 27 years since an attack on a U.S. military convoy in the Middle East left Army reservist ...
